Meta-Analysis Evaluating the Effect of Sodium-Glucose Co-Transporter-2 Inhibitors on Pulmonary Artery Pressure Indices

被引:0
作者
Patoulias, Dimitrios [1 ]
Doumas, Michael [1 ]
Papadopoulos, Christodoulos [2 ]
机构
[1] Aristotle Univ Thessaloniki, Propedeut Dept Internal Med 2, Gen Hosp Hippokrat, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Dept Cardiol 3, Gen Hosp Hippokrat, Thessaloniki, Greece
关键词
HEART-FAILURE; OUTCOMES;
D O I
10.1016/j.amjcard.2022.03.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:169 / 170
页数:3
相关论文
共 9 条
[1]   Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial [J].
Abraham, William T. ;
Stevenson, Lynne W. ;
Bourge, Robert C. ;
Lindenfeld, Jo Ann ;
Bauman, Jordan G. ;
Adamson, Philip B. .
LANCET, 2016, 387 (10017) :453-461
[2]   High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease [J].
Bolignano, Davide ;
Lennartz, Simone ;
Leonardis, Daniela ;
D'Arrigo, Graziella ;
Tripepi, Rocco ;
Emrich, Insa E. ;
Mallamaci, Francesca ;
Fliser, Danilo ;
Heine, Gunnar ;
Zoccali, Carmine .
KIDNEY INTERNATIONAL, 2015, 88 (01) :130-136
[3]   SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control [J].
Cowie, Martin R. ;
Fisher, Miles .
NATURE REVIEWS CARDIOLOGY, 2020, 17 (12) :761-772
[4]   Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction [J].
Dalos, Daniel ;
Mascherbauer, Julia ;
Zotter-Tufaro, Caroline ;
Duca, Franz ;
Kammerlander, Andreas A. ;
Aschauer, Stefan ;
Bonderman, Diana .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (02) :189-199
[5]  
Kjaer A, 2022, DIABETES, DOI [10.2337/db21-0721, DOI 10.2337/DB21-0721]
[6]   Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure Results From the EMBRACE-HF Trial [J].
Nassif, Michael E. ;
Qintar, Mohammed ;
Windsor, Sheryl L. ;
Jermyn, Rita ;
Shavelle, David M. ;
Tang, Fengming ;
Lamba, Sumant ;
Bhatt, Kunjan ;
Brush, John ;
Civitello, Andrew ;
Gordon, Robert ;
Jonsson, Orvar ;
Lampert, Brent ;
Pelzel, Jamie ;
Kosiborod, Mikhail N. .
CIRCULATION, 2021, 143 (17) :1673-1686
[7]   Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction [J].
Omar, Massar ;
Jensen, Jesper ;
Frederiksen, Peter H. ;
Kistorp, Caroline ;
Videbaek, Lars ;
Poulsen, Mikael Kjaer ;
Moller, Soren ;
Ali, Mulham ;
Gustafsson, Finn ;
Kober, Lars ;
Borlaug, Barry A. ;
Schou, Morten ;
Moller, Jacob Eifer .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (23) :2740-2751
[8]   SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials [J].
Zelniker, Thomas A. ;
Wiviott, Stephen D. ;
Raz, Itamar ;
Im, Kyungah ;
Goodrich, Erica L. ;
Bonaca, Marc P. ;
Mosenzon, Ofri ;
Kato, Eri T. ;
Cahn, Avivit ;
Furtado, Remo H. M. ;
Bhatt, Deepak L. ;
Leiter, Lawrence A. ;
McGuire, Darren K. ;
Wilding, John P. H. ;
Sabatine, Marc S. .
LANCET, 2019, 393 (10166) :31-39
[9]   Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis [J].
Zhang, Da-Peng ;
Xu, Li ;
Wang, Le-Feng ;
Wang, Hong-Jiang ;
Jiang, Feng .
CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)